Endometrial Cancer

AstraZeneca Receives Nod To Launch Lynparza For Advanced Endometrial Cancer Treatment In India

AstraZeneca Pharma India said that its firm has received CDSCO approval for the import of the 100 mg and 150 mg strength film-coated tablets of Lynparza, a drug approved for a new indication in the treatment of advanced or recurrent endometrial cancer. The drug maker on Tuesday announced the approval,...